↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Tyck till om SwePub Sök här!

Träfflista för sökning "WFRF:(Goodman M.) "

Search: WFRF:(Goodman M.)

Result 1-10 of 346

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Multimessenger observations of a flaring blazar coincident with high-energy neutrino IceCube-170922A 2018 In: Science. - : American Association for the Advancement of Science. - 0036-8075 .- 1095-9203. ; 361:6398 Journal article (peer-reviewed)
2.	Ray, KK, et al. (author) Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 2019 In: The lancet. Diabetes & endocrinology. - 2213-8595 .- 2213-8587. ; 7:8, s. 618-628 Journal article (peer-reviewed)
3.	Jukema, JW, et al. (author) Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 74:9, s. 1167-1176 Journal article (peer-reviewed)
4.	Roe, MT, et al. (author) Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes 2019 In: Circulation. - : Ovid Technologies (Wolters Kluwer Health). - 1524-4539 .- 0009-7322. ; 140:19, s. 1578-1589 Journal article (peer-reviewed)
5.	Steg, PG, et al. (author) Effect of Alirocumab on Mortality After Acute Coronary Syndromes 2019 In: Circulation. - 1524-4539. ; 140:2, s. 103-112 Journal article (peer-reviewed)
6.	Szarek, M, et al. (author) Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial 2019 In: Circulation. Cardiovascular quality and outcomes. - : Ovid Technologies (Wolters Kluwer Health). - 1941-7705 .- 1941-7713. ; 12:11, s. e005858- Journal article (peer-reviewed)
7.	Szarek, M, et al. (author) Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 73:4, s. 387-396 Journal article (peer-reviewed)
8.	Calabresi, PA, et al. (author) The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL 2007 In: Neurology. - : Ovid Technologies (Wolters Kluwer Health). - 1526-632X .- 0028-3878. ; 69:14, s. 1391-1403 Journal article (peer-reviewed)
9.	Bittner, VA, et al. (author) Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome 2020 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 75:2, s. 133-144 Journal article (peer-reviewed)
10.	Goodman, SG, et al. (author) Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 74:9, s. 1177-1186 Journal article (peer-reviewed)

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-10 of 346

Refine your search

Type of publication: journal article (323); research review (11); conference paper (10); reports (1); book chapter (1)

Type of content: peer-reviewed (327); other academic/artistic (19)

Author/Editor: Madsen, J. (92); Sarkar, S. (92); Stanev, T. (91); Spiering, C. (88); Karle, A. (87); Taboada, I. (87); show more...; Kolanoski, H. (86); Blaufuss, E. (86); Desiati, P. (86); Gaisser, T. K. (86); Gerhardt, L. (86); Halzen, F. (86); Helbing, K. (86); Hoshina, K. (86); Mase, K. (86); Montaruli, T. (86); Nahnhauer, R. (86); Olivas, A. (86); Pieloth, D. (86); Rawlins, K. (86); Resconi, E. (86); Rhode, W. (86); Rott, C. (86); Ryckbosch, D. (86); Schmidt, T. (86); Seunarine, S. (86); Stezelberger, T. (86); Bai, X. (85); Kowalski, M. (85); Berley, D. (85); Bernardini, E. (85); Filimonov, K. (85); Gallagher, J. (85); Goldschmidt, A. (85); Hanson, K. (85); Hultqvist, K. (85); Ishihara, A. (85); Karg, T. (85); Morse, R. (85); Seckel, D. (85); Tilav, S. (85); Sander, H. G. (84); Van Eijndhoven, N. (84); Adams, J. (84); Berghaus, P. (84); Christy, B. (84); Fadiran, O. (84); Goodman, J. A. (84); Kohnen, G. (84); Labare, M. (84); show less...

University: Uppsala University (169); Karolinska Institutet (115); Stockholm University (95); Umeå University (58); Lund University (52); University of Gothenburg (24); show more...; Royal Institute of Technology (18); Linnaeus University (18); Linköping University (17); Chalmers University of Technology (13); Luleå University of Technology (2); Malmö University (1); Stockholm School of Economics (1); Swedish Museum of Natural History (1); Marie Cederschiöld högskola (1); IVL Swedish Environmental Research Institute (1); show less...

Language: English (346)

Research subject (UKÄ/SCB): Medical and Health Sciences (143); Natural sciences (137); Engineering and Technology (7); Social Sciences (3); Humanities (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view